Proinflammatory cytokines, including tumor necrosis factor-alpha (TNF-alpha) might be, at least partially, responsible for the development of osteopenia or osteoporosis in Crohn's disease. We investigated whether anti-TNF therapy for Crohn's disease could have any skeletal impact. Therefore, we studied the effects of infliximab, a monoclonal antibody against TNF-alpha with and without bisphosphonates, on spinal bone mineral density (BMD). The effect of corticosteroids was also analyzed. A ret...Expand abstract
- Publisher copy:
- Copyright date:
The effect of anti-TNF-alpha therapy on spinal bone mineral density in patients with Crohn's disease.
Views and Downloads
If you are the owner of this record, you can report an update to it here: Report update to this record